Theratechnologies Inc.

NASDAQ:THTX

1.28 (USD) • At close October 17, 2024
Bedrijfsnaam Theratechnologies Inc.
Symbool THTX
Munteenheid USD
Prijs 1.28
Beurswaarde 58,854,423
Dividendpercentage 0%
52-weken bereik 0.88 - 2.58
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Paul Lévesque
Website https://www.theratech.com

An error occurred while fetching data.

Over Theratechnologies Inc.

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and

Vergelijkbare Aandelen

Ocular Therapeutix, Inc. logo

Ocular Therapeutix, Inc.

OCUL

11.09 USD

ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc.

CLPT

12.06 USD

4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc.

FDMT

8.45 USD

Verastem, Inc. logo

Verastem, Inc.

VSTM

2.66 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)